| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/07/2012 | CA2431219C Oligonucleotide transfection screening method |
| 02/07/2012 | CA2422856C Methods and kits for decreasing interferences of assay samples containing plasma or serum in specific binding assays by using a large polycation |
| 02/07/2012 | CA2394850C Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 02/07/2012 | CA2382488C Method for the detection of oxidized forms of soluble guanylate cyclase and a method for screening post activators of soluble guanylate cyclase with oxidized haem iron |
| 02/07/2012 | CA2348971C Novel serine proteases bssp4 |
| 02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/07/2012 | CA2273196C Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2012 | CA2264484C Human plasma hyaluronidase |
| 02/06/2012 | CA2747184A1 Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population |
| 02/05/2012 | CA2712213A1 Method and apparatus to perform limited two dimensional separation of proteins and other biologicals |
| 02/02/2012 | WO2012016182A1 C-src selected reaction monitoring assay |
| 02/02/2012 | WO2012016173A2 Safe and functional humanized antibodies |
| 02/02/2012 | WO2012016150A2 Methods for predicting risk of stroke |
| 02/02/2012 | WO2012016136A2 Microscale and nanoscale structures for manipulating particles |
| 02/02/2012 | WO2012016113A1 Biomarker assays for detecting or measuring inhibition of tor kinase activity |
| 02/02/2012 | WO2012016107A1 Methods and kits for detection of salmonella enteritidis and related serovars |
| 02/02/2012 | WO2012016042A2 Glatiramer acetate molecular weight markers |
| 02/02/2012 | WO2012015926A2 Devices and methods for filtering blood plasma |
| 02/02/2012 | WO2012015904A2 Biomarkers for prostate cancer and methods using the same |
| 02/02/2012 | WO2012015599A1 Methods to identify targets and molecules regulating purinosomes and their uses |
| 02/02/2012 | WO2012015592A2 Method and device for reference point indentation without a reference probe |
| 02/02/2012 | WO2012015365A1 Semi -automatic machine for the preparation of drop plates |
| 02/02/2012 | WO2012015327A1 Test system for determining a heart-type fatty acid-binding protein and troponin i (variants) |
| 02/02/2012 | WO2012015249A2 Method for screening diabetes treating agent |
| 02/02/2012 | WO2012015219A2 Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry |
| 02/02/2012 | WO2012015200A2 Composition for diagnosing, treating, and preventing liver disease |
| 02/02/2012 | WO2012015050A1 Method for detection of cleavage product of soluble amyloid-β precursor protein 770β for diagnosis of diseases associated with accumulation of amyloid-β peptide |
| 02/02/2012 | WO2012015029A1 Sugar chain array |
| 02/02/2012 | WO2012015028A1 Method for preparing sugar chains from antibodies |
| 02/02/2012 | WO2012015008A1 Anti-tumor agent |
| 02/02/2012 | WO2012014997A1 Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method |
| 02/02/2012 | WO2012014996A1 Reagent and reagent kit for measurement of fdp, and measurement method |
| 02/02/2012 | WO2012014988A1 Method for manufacturing a probe containing rna for detecting a target base |
| 02/02/2012 | WO2012014897A1 Tissue array production method |
| 02/02/2012 | WO2012014795A1 Novel ret fused body detection method |
| 02/02/2012 | WO2012014778A1 Method for detecting dilute particles in solution using luminescent probe |
| 02/02/2012 | WO2012014346A1 Total phosphorous quantity determination method |
| 02/02/2012 | WO2012014257A1 Total phosphorous quantity determination method |
| 02/02/2012 | WO2012013959A1 Sample plate |
| 02/02/2012 | WO2012013955A1 Method for detecting the presence of a gynaecological growth |
| 02/02/2012 | WO2012013933A1 Analytical method for fab and fab' molecules |
| 02/02/2012 | WO2012013862A1 Use of blood group status |
| 02/02/2012 | WO2012013849A1 Identification and security device using short-distance ocular biometry |
| 02/02/2012 | WO2012013799A1 Method and compositions for the identification of agents that have a potential effect against chronic inflammatory diseases |
| 02/02/2012 | WO2012013758A2 Method for detection of ischemic strokes |
| 02/02/2012 | WO2012013712A1 Markers for determining chondrocytes |
| 02/02/2012 | WO2012013693A1 Covalent immobilization of molecules comprising an amino group |
| 02/02/2012 | WO2012013667A1 Analyses of analytes by mass spectrometry with values in at least 3 dimensions |
| 02/02/2012 | WO2012013619A1 Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto |
| 02/02/2012 | WO2012013617A2 Polymeric complements to b-amyloid peptides |
| 02/02/2012 | WO2012013614A1 Method for the identification of catechol o-methyltransferase modulators |
| 02/02/2012 | WO2012013480A1 Methods and compositions for stimulating a felidae t1r receptor. |
| 02/02/2012 | WO2012013437A1 Method for stabilizing a concentration of a constituent in a solder bath |
| 02/02/2012 | WO2012013311A1 Process for making array |
| 02/02/2012 | WO2012013204A1 Novel ultrasensitive cell based sensors and uses thereof |
| 02/02/2012 | WO2012012874A1 Immunogenic anti-inflammatory compositions |
| 02/02/2012 | WO2012012851A1 Recombinant neisseria meningitidis por a porin proteins. |
| 02/02/2012 | WO2012006240A4 Novel catalyst mixtures |
| 02/02/2012 | WO2011156913A3 An optical pathogen detection system and quality control materials for use in same |
| 02/02/2012 | WO2011152566A3 Composition for inducing proliferation or accumulation of regulatory t cells |
| 02/02/2012 | WO2011151076A3 Monoclonal antibodies targeting amyloid beta oligomers |
| 02/02/2012 | WO2011130595A3 Sirtuin activators and activation assays |
| 02/02/2012 | WO2011129762A9 Method and kit for cancer diagnosis |
| 02/02/2012 | WO2011127453A3 Methods for diagnosis of colorectal cancer |
| 02/02/2012 | WO2011127040A3 High throughput screening of ion channels |
| 02/02/2012 | WO2011126249A3 Chip for fluid analysis wherein fluid moves without external power |
| 02/02/2012 | WO2011116006A3 A rapid method to measure cyanide in biological samples |
| 02/02/2012 | WO2011110650A3 Hmgb1 and anti-hmgb1 antibodies for the prognostic of neurological disorders |
| 02/02/2012 | WO2011109806A9 Biomarkers for the identification, monitoring, and treatment of non-small cell lung cancer (nsclc) |
| 02/02/2012 | WO2011109214A3 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same |
| 02/02/2012 | WO2011106536A3 Methods of diagnosing infectious disease pathogens and their drug sensitivity |
| 02/02/2012 | WO2011106401A3 Methods and compositions relating to multiciliate cell differentiation |
| 02/02/2012 | WO2011106322A3 Biomarkers for acute ischemic stroke |
| 02/02/2012 | WO2011105820A3 Enzyme column and method for manufacturing same |
| 02/02/2012 | WO2011102680A3 Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway |
| 02/02/2012 | WO2011084047A3 Identification of molecular markers associated with fatty acid composition in plants |
| 02/02/2012 | WO2009111599A3 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 02/02/2012 | WO2001080622A3 Apparatus and methods for assays of one or more analytes |
| 02/02/2012 | US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 02/02/2012 | US20120030777 Methods for testing for caloric restriction (cr) mimetics |
| 02/02/2012 | US20120029833 Assessment method to process a glucose concentration signal and devices thereof |
| 02/02/2012 | US20120029832 Apparatus and method for distribution of biological material |
| 02/02/2012 | US20120029331 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry |
| 02/02/2012 | US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 02/02/2012 | US20120028972 Biomarker assays for detecting or measuring inhibition of tor kinase activity |
| 02/02/2012 | US20120028901 Tfpi inhibitors and methods of use |
| 02/02/2012 | US20120028881 Methods and reagents for diagnosing atheroma |
| 02/02/2012 | US20120028879 Highly sensitive detection method for highly virulent oral cavity bacteria |
| 02/02/2012 | US20120028850 Microfluidic device for simultaneously conducting multiple analyses |
| 02/02/2012 | US20120028846 Gas sensor incorporating a porous framework |
| 02/02/2012 | US20120028838 Quantification of Gene Expression |
| 02/02/2012 | US20120028837 Rapid screen for reproductive toxicants |
| 02/02/2012 | US20120028836 Use of protein satb2 as a marker for colorectal cancer |
| 02/02/2012 | US20120028835 Secernin-1 as a marker for cancer |
| 02/02/2012 | US20120028830 Microfluidic device for simultaneously conducting multiple analyses |
| 02/02/2012 | US20120028829 Anti-hedgehog antibodies |
| 02/02/2012 | US20120028828 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification |
| 02/02/2012 | US20120028825 Galectin-1 (gal1) as a biomarker for differential diagnosis of osteosarcoma and chondrosarcoma |
| 02/02/2012 | US20120028824 Method for the in vitro diagnosis of stroke |
| 02/02/2012 | US20120028821 Programming and reprogramming of cells |